- Home
- INDV vs KFY Comparison
INDV vs KFY Comparison
Compare INDV & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | KFY |
|---|---|---|
| Founded | N/A | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.4B |
| IPO Year | 2014 | 1998 |
Fundamental Metrics
Financial Performance| Metric | INDV | KFY |
|---|---|---|
| Price | $32.54 | $64.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $73.00 |
| AVG Volume (30 Days) | ★ 2.2M | 482.7K |
| Earning Date | 06-08-2026 | 03-09-2026 |
| Dividend Yield | N/A | ★ 3.03% |
| EPS Growth | ★ 8100.00 | 42.41 |
| EPS | 1.64 | ★ 3.84 |
| Revenue | $1,239,000,000.00 | ★ $1,819,519,000.00 |
| Revenue This Year | N/A | $6.92 |
| Revenue Next Year | N/A | $3.25 |
| P/E Ratio | $20.09 | ★ $16.48 |
| Revenue Growth | 4.29 | ★ 12.20 |
| 52 Week Low | $8.69 | $58.27 |
| 52 Week High | $38.00 | $78.50 |
Technical Indicators
Market Signals| Indicator | INDV | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 55.28 |
| Support Level | $31.70 | $61.98 |
| Resistance Level | $32.42 | $65.02 |
| Average True Range (ATR) | 1.18 | 1.88 |
| MACD | 0.39 | 0.14 |
| Stochastic Oscillator | 73.89 | 81.63 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.